Cargando…
Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?
The new targeted cancer therapies including immune checkpoint inhibitors (ICIs) have been demonstrated to improve the survival of oncological patients, even in cases of metastatic cancer. In the past 5 years, several studies have revealed that ICI can produce several immune-mediated toxicities invol...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237407/ https://www.ncbi.nlm.nih.gov/pubmed/35775000 http://dx.doi.org/10.3389/fmed.2022.906565 |